Sunday, 27 November 2011

Elan, Cambridge University Link To Study Degenerative Brain Disease

Irish drug maker Elan Corporation PLC (ELN) and Cambridge University said Sunday they have formed a 10-year collaboration to study degenerative brain disorders. The Cambridge-Elan Centre for Research Innovation and Drug Discovery will aim to discover novel compounds capable of altering the behavior ...


Related News:-

  • Tysabri News


  • Timothy L. Vollmer, MD Professor Department of Neurology University of Colorado Health Sciences Center Co-Director of the RMMSC at Anschutz Medical Center
  • www.canis.uiuc.edu


  • tysabri Boost for Elan as Tysabri set for green light Athlon Advertiser - Athlone,Co. The analyst said Tysabri continues to be an "overhang" on the stock, which he values in a ...
  • Kantar Media Intelligence Health News


  • 15/11/2011: Daily Express: How to beat Alzheimer's: The secret to beating Alzheimer's lies in potent vaccines, scientists have found. The latest tests, in the US, found ...
  • MSRC Latest MS Research News


  • All the latest breaking MS Research News from around the world, brought to you in one place on the Multiple Sclerosis Resource Centre's Latest MS Research News.
  • www2f.biglobe.ne.jp


  • 1.Reminyl, A Novel Alzheimer's Treatment, Receives First EU Approval( March 3 2000) 2.Experts fear large increase in Alzheimer's as more people live longer(July 11, 2000)
  • EDGAR Pro


  • Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
  • ISMRM 19th Annual Meeting


  • Electronic Posters : Neuroimaging: Click on to view the abstract pdf and click on to view the video presentation.

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...